美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aevi Genomic Medicine Inc

0.1659

+0.0000

成交量：- -

成交額：- -

市值：1,289.27萬

市盈率：-0.56

高：0.1659

開：0.1659

低：0.1659

收：0.1659

資料載入中...

總覽公司新聞公告

公司資料

公司名字：

Aevi Genomic Medicine Inc

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.medgenics.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Medgenics, Inc.於2000年1月27日在特拉華州成立，其全資附屬公司 Medgenics Medical(以色列）Limited在以色列國依法成立。該公司從事於醫療技術和治療，開發專有創新技術平台，為一千多億美元的蛋白質療法市場提供新的療法。其BiopumpTM平台技術將患者的真皮組織轉成可形成蛋白質的“生物泵”，以在患者體內持續生產治療性蛋白質。當植入患者的皮下組織時，可以提供數月的蛋白療法，而不需要一系列頻繁注射。其Biopump平台技術已被驗證可以使用EPODURETM為貧血治療提供促紅細胞生成素（EPO），且貧血患者的血紅蛋白显示出高水平和穩定性，而這些患者大都是在I/II期用藥達6個月及以上的慢性腎臟病（CKD）患者，且試驗結果显示其中一個病人在長達36月內穩定在高血紅蛋白水平。其Biopump是組織微泵（MO），形成於患者的牙籤大小的皮膚組織，可以產生並分泌特定的蛋白質。該公司已經開發出名為DermaVac的專有設備，以方便微泵的去除和Biopumps的植入。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/GNMX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Aevi Genomic Medicine Inc","latestPrice":0.1659,"timestamp":1580763600000,"preClose":0.1659,"halted":4,"volume":0,"delay":0,"floatShares":67896168,"shares":77713782,"eps":-0.295664,"marketStatus":"退市","change":0,"latestTime":"05-01 16:20:19 EDT","open":0.1659,"high":0.1659,"low":0.1659,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.295664,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"NASDAQ","adjPreClose":0.1659,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":67896168,"roa":"-104.54%","roe":"-372.06%","lyrEps":-0.501371,"shares":77713782,"dividePrice":0,"high":0.1659,"amplitude":0,"preClose":0.1659,"low":0.1659,"week52Low":0.11,"pbRate":"38.83","week52High":0.347,"institutionHeld":0,"latestPrice":0.1659,"eps":-0.295664,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.295664,"open":0.1659},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.medgenics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0357},{"period":"1month","weight":-0.0087},{"period":"3month","weight":-0.0835},{"period":"6month","weight":-0.0289},{"period":"1year","weight":0.1047},{"period":"ytd","weight":-0.0538}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Medgenics, Inc.於2000年1月27日在特拉華州成立，其全資附屬公司 Medgenics Medical(以色列）Limited在以色列國依法成立。該公司從事於醫療技術和治療，開發專有創新技術平台，為一千多億美元的蛋白質療法市場提供新的療法。其BiopumpTM平台技術將患者的真皮組織轉成可形成蛋白質的“生物泵”，以在患者體內持續生產治療性蛋白質。當植入患者的皮下組織時，可以提供數月的蛋白療法，而不需要一系列頻繁注射。其Biopump平台技術已被驗證可以使用EPODURETM為貧血治療提供促紅細胞生成素（EPO），且貧血患者的血紅蛋白显示出高水平和穩定性，而這些患者大都是在I/II期用藥達6個月及以上的慢性腎臟病（CKD）患者，且試驗結果显示其中一個病人在長達36月內穩定在高血紅蛋白水平。其Biopump是組織微泵（MO），形成於患者的牙籤大小的皮膚組織，可以產生並分泌特定的蛋白質。該公司已經開發出名為DermaVac的專有設備，以方便微泵的去除和Biopumps的植入。","exchange":"NASDAQ","name":"Aevi Genomic Medicine Inc","nameEN":"Aevi Genomic Medicine Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-14","symbol":"GNMX","fiscalQuarterEnding":"2019/09","expectedEps":-0.05,"name":null,"time":"","type":"earning","dateTimestamp":1573707600000,"reportTimeType":"","actualEps":-0.06},{"market":"US","date":"2019-08-13","symbol":"GNMX","fiscalQuarterEnding":"2019/06","expectedEps":-0.1,"name":null,"time":"","type":"earning","dateTimestamp":1565668800000,"reportTimeType":"","actualEps":-0.06},{"market":"US","date":"2019-05-14","symbol":"GNMX","fiscalQuarterEnding":"2019/03","expectedEps":-0.1,"name":null,"time":"","type":"earning","dateTimestamp":1557806400000,"reportTimeType":"","actualEps":-0.07},{"market":"US","date":"2018-11-01","symbol":"GNMX","fiscalQuarterEnding":"2018/09","expectedEps":-0.16,"name":null,"time":"","type":"earning","dateTimestamp":1541044800000,"reportTimeType":"","actualEps":-0.12},{"market":"US","date":"2018-08-02","symbol":"GNMX","fiscalQuarterEnding":"2018/06","expectedEps":-0.15,"name":null,"time":"","type":"earning","dateTimestamp":1533182400000,"reportTimeType":"","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{}}}